24 HR pregabalin 82.5 MG Extended Release Oral Tablet

RxCUI
1988980
RxNorm name
24 HR pregabalin 82.5 MG Extended Release Oral Tablet
Display name
24 HR pregabalin 82.5 MG Extended Release Oral Tablet
Full name
24 HR pregabalin 82.5 MG Extended Release Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PREGABALINPREGABALINNovadoz Pharmaceuticals LLCf6aa5977-97c8-4a56-8e35-d9ab5cc243692026-06-10Warnings, Adverse reactionsExact identifier
rxcui: 1988980
Lyrica CRPREGABALINViatris Specialty LLCf280bbd8-2af2-444a-bd96-e409337ca6dd2026-03-12Warnings, Adverse reactionsExact identifier
rxcui: 1988980
PregabalinPREGABALINAdvagen Pharma Ltd.2ffee7e7-bfa0-4933-9baf-7df55080816e2026-02-04Warnings, Adverse reactionsExact identifier
rxcui: 1988980
Pregabalin Extended ReleasePREGABALINScieGen Pharmaceuticals, INC.1544a657-353c-47f8-96ac-a63fa78373f02022-09-19Warnings, Adverse reactionsExact identifier
rxcui: 1988980

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f280bbd8-2af2-444a-bd96-e409337ca6dd24 HR pregabalin 82.5 MG Extended Release Oral TabletSCD7These highlights do not include all the information needed to use LYRICA CR safely and effectively. See full prescribing information for LYRICA CR. LYRICA ® CR (pregabalin) extended-release tablets, for oral use, CV Initial U.S. Approval: 200420260312
f280bbd8-2af2-444a-bd96-e409337ca6ddpregabalin 82.5 MG 24HR Extended Release Oral TabletPSN7These highlights do not include all the information needed to use LYRICA CR safely and effectively. See full prescribing information for LYRICA CR. LYRICA ® CR (pregabalin) extended-release tablets, for oral use, CV Initial U.S. Approval: 200420260312
2ffee7e7-bfa0-4933-9baf-7df55080816e24 HR pregabalin 82.5 MG Extended Release Oral TabletSCD4These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED-RELEASE TABLETS. PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 200420260204
2ffee7e7-bfa0-4933-9baf-7df55080816epregabalin 82.5 MG 24HR Extended Release Oral TabletPSN4These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED-RELEASE TABLETS. PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 200420260204
16e00b09-671b-45bc-a6df-6a0d692b256d24 HR pregabalin 82.5 MG Extended Release Oral TabletSCD2These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED-RELEASE TABLETS. PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 200420230606
16e00b09-671b-45bc-a6df-6a0d692b256dpregabalin 82.5 MG 24HR Extended Release Oral TabletPSN2These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED-RELEASE TABLETS. PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 200420230606
1544a657-353c-47f8-96ac-a63fa78373f0pregabalin 82.5 MG 24HR Extended Release Oral TabletPSN1These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED-RELEASE TABLETS . PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 200420220919
1544a657-353c-47f8-96ac-a63fa78373f024 HR pregabalin 82.5 MG Extended Release Oral TabletSCD1These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED-RELEASE TABLETS . PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 200420220919
f6aa5977-97c8-4a56-8e35-d9ab5cc2436924 HR pregabalin 82.5 MG Extended Release Oral TabletSCD1These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED- RELEASE TABLETS. PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 200420201212
f6aa5977-97c8-4a56-8e35-d9ab5cc24369pregabalin 82.5 MG 24HR Extended Release Oral TabletPSN1These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED- RELEASE TABLETS. PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 200420201212